Policy document
November 20th 2015

Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries

Flag of USA USA
U.S. Government Accountability Office
U.S. Government Accountability Office
https://www.gao.gov Flag of usa USA

The Government Accountability Office (GAO) is a legislative branch government agency that provides auditing, evaluation, and investigative services for the United States Congress.
New Medicare Part B drugs were more likely than new drugs not paid under Part B to be biologics, that is, products derived from living sources; be approved to treat a narrower range of conditions; and to have used a Food and Drug Administration (FDA) program to expedite their development and review.

Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer?

If you fund, produce or manage research or work to influence policy, we'd love to talk.

Request a free trial Learn more

Language: eng
39 pages

Download PDF

Identifiers

Overton ID
gaogov-3a1447a195173995f64dd3fda05e78e5

Topics in this document

Pharmaceutical sciences New Drug Application Clinical trial Food and Drug Administration Priority review Drug development Orphan drug Biopharmaceutical Phases of clinical research Fast track (FDA) Government Accountability Office Health care Pharmacy Health Medical specialties Drugs Health sciences Health policy Pharmacology Clinical medicine Medicine Medical treatments Healthcare industry Medicare (United States) Breakthrough therapy Federal Food, Drug, and Cosmetic Act Medical research Cancer Medicinal chemistry Medicare Part D

Related SDGs

SDG 3: Good Health and Well-being
SDG 3: Good Health and Well-being

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Related COFOG Divisions

7: Health 7.1: Medical Products, Appliances and Equipment

Citations

Cited by 25 other policy documents (22 of them are from other policy sources)